Carl Meisner
Family Medicine · Sugar Land, TXNPI 1184610529
Payments from drug & device makers
Across 489 payments — averaging $1023.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$271K
- Eli Lilly$92K
- Bayer$85K
- Sanofi-aventis U.S. LLC$30K
- Amgen$17K
- AbbVie$6K
Across 169 payments — averaging $665.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$81K
- Novo Nordisk AS$28K
- Sanofi US Services Inc.$3K
What the payments were for
- Travel & lodging$1,67774%
- Food & beverage$59026%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 408 | $270,692 |
| Eli Lilly | 29 | $92,159 |
| Bayer | 36 | $84,739 |
| Sanofi-aventis U.S. LLC | 5 | $30,268 |
| Amgen | 6 | $17,025 |
| AbbVie | 5 | $5,600 |
How this compares
$500,483 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Sugar Land
- Wilner JeudySugar Land$6M
- Ronald PucilloSugar Land$5.1M
- Mehjabin ParkarSugar Land$3.9M
- John VanderzylSugar Land$3.8M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.